Abstract:ABSTRACT Kaposi's sarcoma-associated herpesvirus (KSHV) is a typical gammaherpesvirus that establishes persistent lifelong infection in host cells. In order to establish successful infection, KSHV has evolved numerous immune evasion strategies to bypass or hijack the host immune system. However, host cells still produce immune cytokines abundantly during primary KSHV infection. Whether the immune effectors produced are able to inhibit viral infection and how KSHV successfully conquers these immune effectors remain largely unknown. The guanylate-binding protein 1 (GBP1) gene is an interferon-stimulated gene and exerts antiviral functions on several RNA viruses; however, its function in DNA virus infection is less well understood. In this study, we found that KSHV infection increases both the transcriptional and protein levels of GBP1 at the early stage of primary infection by activating the NF-κB pathway. The overexpression of GBP1 significantly inhibited KSHV infection, while the knockdown of GBP1 promoted KSHV infection. The GTPase activity and dimerization of GBP1 were demonstrated to be responsible for its anti-KSHV activity. Furthermore, we found that GBP1 inhibited the nuclear delivery of KSHV virions by disrupting the formation of actin filaments. Finally, we demonstrated that replication and transcription activator (RTA) promotes the degradation of GBP1 through a proteasome pathway. Taken together, these results provide a new understanding of the antiviral mechanism of GBP1, which possesses potent anti-KSHV activity, and suggest the critical role of RTA in the evasion of the innate immune response during primary infection by KSHV. IMPORTANCE GBP1 can be induced by various cytokines and exerts antiviral activities against several RNA viruses. Our study demonstrated that GBP1 can exert anti-KSHV function by inhibiting the nuclear delivery of KSHV virions via the disruption of actin filaments. Moreover, we found that KSHV RTA can promote the degradation of GBP1 through a proteasome-mediated pathway. Taken together, our results elucidate a novel mechanism of GBP1 anti-KSHV activity and emphasize the critical role of RTA in KSHV evasion of the host immune system during primary infection.

Guanylate‐binding protein 1 inhibits Hantaan virus infection by restricting virus entry

Guanylate-Binding Protein 1 Inhibits Inflammatory Factors Produced by H5N1 Virus Through Its GTPase Activity

Guanylate-binding Protein 1 Participates in Cellular Antiviral Response to Dengue Virus

Guanylate-Binding Protein 1 Inhibits Nuclear Delivery of Kaposi's Sarcoma-Associated Herpesvirus Virions by Disrupting Formation of Actin Filament

Hantaan Virus Inhibits Type I Interferon Response by Targeting RLR Signaling Pathways Through TRIM25

Hantaan virus inhibits type I interferon response by targeting RLRs signaling pathways through TRIM25

Guanylate-binding Protein 1 Inhibits Nuclear Delivery of Pseudorabies Virus by Disrupting Structure of Actin Filaments

Guanylate-binding Protein 1 Restricts Avian Coronavirus Infectious Bronchitis Virus-Infected HD11 Cells

IFN-λs inhibit Hantaan virus infection through the JAK-STAT pathway and expression of Mx2 protein

Guanylate-binding protein 1 acts as a pro-viral factor for the life cycle of hepatitis C virus

Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection

Tupaia guanylate-binding protein 1 interacts with vesicular stomatitis virus phosphoprotein and represses primary transcription of the viral genome.

Antiviral effect of interferon-induced guanylate binding protein-1 against Coxsackie virus and Hepatitis B virus B3 in Vitro

Human Guanylate-Binding Protein 1 Positively Regulates Japanese Encephalitis Virus Replication in an Interferon Gamma Primed Environment

Interferon-γ-induced GBP1 is an inhibitor of human papillomavirus 18

Guanylate-binding protein 5 antagonizes viral glycoproteins independently of furin processing

Guanylate binding protein 4 negatively regulates virus-induced type I IFN and antiviral response by targeting IFN regulatory factor 7.

Antiviral effect of guanylate binding protein-1 against coxsackievirus B3 and hepatitis B virus in vitro

T-cell immunoglobulin and mucin 1 (TIM-1) mediates infection of Hantaan virus in Jurkat T cells

Porcine reproductive and respiratory syndrome virus non-structural protein 4 cleaves guanylate-binding protein 1 via its cysteine proteinase activity to antagonize GBP1 antiviral effect